Skip to the page

Data / Medical devices / United States / Regenesis Biomedical, Inc.

Regenesis Biomedical, Inc.: FDA-registered device maker in Scottsdale, AZ, United States, 2 510(k) clearances

Regenesis Biomedical, Inc. is registered with the FDA (registration 2032108) in Scottsdale, AZ, United States. It lists 2 device types. The FDA files 2 510(k) clearances under its listings, the newest dated May 24, 2023. 1 recall event names it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
2032108
FEI number
3003070149
Address
5301 N Pima Rd Ste 150, Scottsdale, AZ, United States, 85250
Owner or operator
REGENESIS BIOMEDICAL, INC. (9030652)
Roles
Specification developer
First device listed
December 14, 2017
Registered through
2026
Brand names listed
Provant Therapy System, Reprieve by Regenesis

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
May 24, 2023K223620Reprieve by RegenesisTMIMJSubstantially EquivalentRegenesis Biomedical, Inc.accessdata.fda.gov
December 13, 2013K131979PROVANT THERAPY SYSTEMILXSubstantially EquivalentRegenesis Biomedical, Inc.accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
September 29, 200850230Not yet classifiedTerminatedRegenesis Biomedical PROVANT Wound Therapy System, Model 4201 - The Provant Wound Therapy System is a solid-state, fixed-power output radio frequency generator and transmitter designed to operate at the FCC authorized meIn the course of device testing, the firm determined that the affected devices may, under certain unusual clinical circumstance, be unable to generate a therapeutic dose of radio frequency energy. As such, for these few devices, the effectiveness of Provant therapy may be impaired.accessdata.fda.gov

Compare with other makers

Updated May 24, 2023. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.